The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Urologic Oncology: Seminars and Original Investigations Année : 2017

The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review

Résumé

The neutrophils/lymphocytes ratio (NLR) is a biological marker of inflammation with a demonstrated prognostic value in the field of oncology. In this review we discussed the prognostic value of the NLR in renal cell carcinomas (RCC), where several multiparametric nomograms already existed. For localized RCC, a NLR <3 was predictive of a reduced risk of recurrence. In metastatic or locally advanced RCC, a NLR <3 predicted an increased overall survival, progression-free survivals and response to systemic treatment. In current practice the NLR is a simple costless prognostic factor with potential improvement in the prognostic performance of nomograms used in renal oncology.
Fichier principal
Vignette du fichier
The prognostic value.pdf (563.29 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01792761 , version 1 (22-05-2018)

Identifiants

Citer

Romain Boissier, Jennifer Campagna, Nicolas Branger, Gilles Karsenty, Eric Lechevallier. The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review. Urologic Oncology: Seminars and Original Investigations, 2017, pp.135 - 141. ⟨10.1016/j.urolonc.2017.01.016⟩. ⟨hal-01792761⟩

Collections

CNRS UNIV-AMU CRCM
123 Consultations
459 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More